dalteparin
Generic: DALTEPARIN SODIUM·Brand: FRAGMIN
dalteparin: 1 clinical trial tracked.
dalteparin evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about dalteparin, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Multicenter, Randomized, Open-label, Blinded Endpoint Evaluation, Phase 3 Study Comparing the Effect of Abelacimab vs. Dalteparin on Venous Thromboembolism (VTE) Recurrence and Bleeding in Patients With GI/GU Associated VTE
Primary endpoint: Time to first event of centrally adjudicated VTE recurrence
InterventionalRandomizedsingle417 targetStarted 2022-09Completion 2026-0450 sites · Australia, Austria, Canada, China…Anthos Therapeutics, Inc.